Status:

COMPLETED

The Pitt Center for Emergency Responder Wellness

Lead Sponsor:

University of Pittsburgh

Conditions:

Posttraumatic Stress Disorder

Depression

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Emergency responders protect the public despite occupational hazards that threaten their mental health. The Pitt Center for Emergency Responder Wellness will be a clinical innovation hub that: 1) deli...

Detailed Description

Emergency responders protect the public despite occupational hazards that threaten their mental health. This Center will be a clinical innovation hub that: 1) delivers accessible interventions for pro...

Eligibility Criteria

Inclusion

  • Participants will be age 18 or older.
  • They will be emergency responders defined as fire fighters, law enforcement officers, emergency medical service personnel, emergency room medical providers (physicians, nurses, physician assistants), emergency dispatchers, and emergency response trainees who have completed training experiences in which they encountered emergencies.
  • They must reside in Pennsylvania.

Exclusion

  • Are unable or unwilling to complete the study procedures.
  • Receiving another form of therapy our counseling for anxiety, depression, posttraumatic stress, or alcohol use problems. Attendance at self-help programs (e.g., Alcoholics Anonymous) and couples therapy is permitted.
  • Have a history of a psychotic disorder or bipolar disorder.
  • Endorse drug use and symptoms consistent with a non-alcohol substance use disorder except nicotine, caffeine, or cannabis.
  • Are experiencing a current suicidal or homicidal crisis warranting immediate intervention: potential participants may participate later once stabilized.
  • Are currently awaiting the outcome of litigation involving their employment or training as emergency responders or any other reason deemed by the study team to be potentially related to their mental health.
  • Evidence severe organic brain impairment as evidenced by a major apparent disruption of consciousness, cognition, speech, or behavior that would likely interfere with treatment.

Key Trial Info

Start Date :

March 29 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2023

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT05357586

Start Date

March 29 2022

End Date

December 31 2023

Last Update

February 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15260